Follow
Sritama Nath
Sritama Nath
Vor Biopharma, Duke University, University of Michigan, University of North Carolina at Charlotte
Verified email at duke.edu
Title
Cited by
Cited by
Year
Three-dimensional culture systems in cancer research: Focus on tumor spheroid model
S Nath, GR Devi
Pharmacology & therapeutics 163, 94-108, 2016
8762016
MUC1: a multifaceted oncoprotein with a key role in cancer progression
S Nath, P Mukherjee
Trends in molecular medicine 20 (6), 332-342, 2014
7912014
MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
LD Roy, M Sahraei, DB Subramani, D Besmer, S Nath, TL Tinder, E Bajaj, ...
Oncogene 30 (12), 1449-1459, 2011
3132011
MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
S Nath, K Daneshvar, LD Roy, P Grover, A Kidiyoor, L Mosley, M Sahraei, ...
Oncogenesis 2 (6), e51-e51, 2013
1872013
MUC1 regulates PDGFA expression during pancreatic cancer progression
M Sahraei, LD Roy, JM Curry, TL Teresa, S Nath, D Besmer, A Kidiyoor, ...
Oncogene 31 (47), 4935-4945, 2012
992012
X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity
MK Evans, SJ Sauer, S Nath, TJ Robinson, MA Morse, GR Devi
Cell death & disease 7 (1), e2073-e2073, 2016
592016
Mucin 1 regulates Cox-2 gene in pancreatic cancer
S Nath, LD Roy, P Grover, S Rao, P Mukherjee
Pancreas 44 (6), 909-917, 2015
432015
SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line
P Grover, S Nath, MD Nye, R Zhou, M Ahmad, P Mukherjee
Oncotarget 9 (6), 6897, 2018
352018
MicroRNA miR-308 regulates dMyc through a negative feedback loop in Drosophila
K Daneshvar, S Nath, A Khan, W Shover, C Richardson, JM Goodliffe
Biology Open 2 (1), 1-9, 2012
242012
Pancreatic cancer cells isolated from Muc1-null tumors favor the generation of a mature less suppressive MDSC population
A Kidiyoor, J Schettini, DM Besmer, SL Rego, S Nath, JM Curry, LD Roy, ...
Frontiers in Immunology 5, 67, 2014
192014
Repression of MUC1 promotes expansion and suppressive function of myeloid-derived suppressor cells in pancreatic and breast cancer murine models
M Sahraei, M Bose, JA Sanders, C De, L DasRoy, S Nath, CR Brouwer, ...
International journal of molecular sciences 22 (11), 5587, 2021
162021
Overexpression of MUC1 induces non-canonical TGF-β signaling in pancreatic ductal adenocarcinoma
M Bose, P Grover, AJ Sanders, R Zhou, M Ahmad, S Shwartz, P Lala, ...
Frontiers in cell and developmental biology 10, 821875, 2022
152022
Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice
JM Curry, DM Besmer, TK Erick, N Steuerwald, L Das Roy, P Grover, ...
PLoS One 14 (11), e0224309, 2019
152019
P1396: CD33-DELETED HEMATOPOIETIC STEM AND PROGENITOR CELLS DISPLAY NORMAL ENGRAFTMENT AFTER HEMATOPOIETIC CELL TRANSPLANT (HCT) AND TOLERATE POST-HCT GEMTUZUMAB OZOGAMICIN (GO …
G Koehne, B Tomlinson, H Suh, D Koura, C Cho, NM Bambace, ...
HemaSphere 7 (S3), e24418bc, 2023
42023
Trial in Progress: a first-in-human phase 1/2 study of hematopoietic stem cell transplantation (HCT) with VOR33 (CD33-deleted allograft) followed by treatment with gemtuzumab …
BW Cooper, HC Suh, D Koura, G Koehne, C Cho, NM Bambace, ...
Blood 140 (Supplement 1), 12973-12975, 2022
22022
Repression of MUC1 promotes expansion and suppressive function of myeloid-derived suppressor cells in pancreatic ductal adenocarcinoma and breast cancer murine models
S Mahnaz, LD Roy, M Bose, C De, S Nath, P Mukherjee
bioRxiv, 2020.12. 07.415299, 2020
22020
Combinational treatment with MUC1 vaccine and Indomethacin reduces breast tumor burden via a COX-independent pathway.
JM Curry, DM Besmer, L Das Roy, P Grover, S Nath, S Rao, P Mukherjee
Cancer Research 73 (8_Supplement), 475-475, 2013
22013
Transcriptional regulation of genes associated with drug resistance and growth of pancreatic cancer cells by mucin 1
S Nath
The University of North Carolina at Charlotte, 2013
22013
Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients with Relapsed or Refractory Acute Myeloid Leukemia after Allogeneic …
NN Shah, J Azzi, BW Cooper, A Deol, J DiPersio, D Koura, B McClune, ...
Blood 142, 4862, 2023
12023
Tumor-Associated MUC1 Regulates TGF-β Signaling and Function in Pancreatic Ductal Adenocarcinoma
P Grover, S Nath, M Bose, AJ Sanders, C Brouwer, Nitika, R Zhou, ...
bioRxiv, 2020.04. 29.068577, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–20